Literature DB >> 25797693

Hepatitis C viral infection is associated with activated cytolytic natural killer cells expressing high levels of T cell immunoglobulin- and mucin-domain-containing molecule-3.

Lucy Golden-Mason1, Christine E Waasdorp Hurtado2, Linling Cheng1, Hugo R Rosen3.   

Abstract

T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) is an inhibitory receptor implicated in T cell exhaustion characteristic of chronic viral infection. Limited data exist on NK cell Tim-3 expression and functional consequences. In chronic hepatitis C virus (HCV)-infected subjects, we found increased Tim-3 on NKs, which was associated with an activated phenotype. The high level of Tim-3 was not reversed by successful IFN-alpha-based antiviral therapy. Tim-3(high) NK cells up-regulated TRAIL in response to IFN-alpha to a greater extent and demonstrated greater lymphokine-activated killing activity, viral control, and degranulation but similar cytokine production than their Tim-3(low) counterparts. Our results suggest that Tim-3 on NKs is associated with activation of this innate lymphocyte population that is polarized towards cytotoxicity in chronic HCV. These findings reveal roles for Tim-3 in the regulation of NKs that might represent targets for treatment of chronic viral infections.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Cytotoxicity; HCV; Human; IFN-γ; Natural cytotoxicity receptors

Mesh:

Substances:

Year:  2015        PMID: 25797693     DOI: 10.1016/j.clim.2015.03.008

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  14 in total

Review 1.  Role of Tim-3 in hepatitis B virus infection: An overview.

Authors:  Yuan Liu; Li-Fen Gao; Xiao-Hong Liang; Chun-Hong Ma
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 2.  Natural killer cells in inflammatory heart disease.

Authors:  SuFey Ong; Noel R Rose; Daniela Čiháková
Journal:  Clin Immunol       Date:  2016-11-25       Impact factor: 3.969

3.  TIM-3: a crucial regulator of NK cells in pregnancy.

Authors:  Yanhong Li; Dajin Li; Meirong Du
Journal:  Cell Mol Immunol       Date:  2017-09-11       Impact factor: 11.530

4.  The relevance of Tim-3 polymorphisms and F protein to the outcomes of HCV infection.

Authors:  J P Pei; L F Jiang; X W Ji; W Xiao; X Z Deng; Z X Zhou; D Y Zhu; W L Ding; J H Zhang; C J Wang; K Jing
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-26       Impact factor: 3.267

Review 5.  Natural killer cells in liver diseases.

Authors:  Meijuan Zheng; Haoyu Sun; Zhigang Tian
Journal:  Front Med       Date:  2018-04-19       Impact factor: 4.592

6.  Higher expression of inhibitory CD158b and CD158e NK cell receptor and age predicts treatment response in children with chronic hepatitis C.

Authors:  Anna Mania; Mariusz Kaczmarek; Paweł Kemnitz; Katarzyna Mazur-Melewska; Magdalena Figlerowicz; Jan Sikora; Wojciech Służewski; Jan Żeromski
Journal:  Med Microbiol Immunol       Date:  2017-11-08       Impact factor: 3.402

7.  Tim-3 expression represents dysfunctional tumor infiltrating T cells in renal cell carcinoma.

Authors:  Chen Cai; Yi-Fan Xu; Zhen-Jie Wu; Qin Dong; Min-Yu Li; Jason C Olson; Yaron M Rabinowitz; Lin-Hui Wang; Yinghao Sun
Journal:  World J Urol       Date:  2015-08-08       Impact factor: 4.226

8.  Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives.

Authors:  Huan Xu; Mingyang Shi; Changsheng Shao; Hao Li; Jing Wu; Yin Yu; Fang Fang; Yugang Guo; Weihua Xiao
Journal:  Microb Cell Fact       Date:  2021-06-09       Impact factor: 5.328

9.  Polymorphisms in TIM-3 and breast cancer susceptibility in Chinese women: A case-control study.

Authors:  Zheng Wang; Xinghan Liu; Xijing Wang; Tie Chong; Shuai Lin; Meng Wang; Xiaobin Ma; Kang Liu; Peng Xu; Yanjing Feng; Zhijun Dai
Journal:  Oncotarget       Date:  2016-07-12

Review 10.  Detection of Immune Checkpoint Receptors - A Current Challenge in Clinical Flow Cytometry.

Authors:  Benjamin Shibru; Katharina Fey; Stephan Fricke; André-René Blaudszun; Friederike Fürst; Max Weise; Sabine Seiffert; Maria Katharina Weyh; Ulrike Köhl; Ulrich Sack; Andreas Boldt
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.